Drexel Morgan & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$52.8M Hold
216,207
7.75% 3
2025
Q4
$44.7M Hold
216,207
7% 4
2025
Q3
$40.1M Sell
216,207
-50
-0% -$8.57K 6.3% 5
2025
Q2
$33M Hold
216,257
5.87% 5
2025
Q1
$35.9M Hold
216,257
7.53% 3
2024
Q4
$31.3M Hold
216,257
6.45% 3
2024
Q3
$35M Hold
216,257
6.51% 4
2024
Q2
$31.6M Hold
216,257
6.78% 4
2024
Q1
$34.2M Buy
216,257
+160
+0.1% +$25.5K 7.04% 4
2023
Q4
$33.9M Buy
216,097
+100
+0% +$15.3K 7.83% 3
2023
Q3
$33.6M Buy
215,997
+300
+0.1% +$49.5K 9.15% 3
2023
Q2
$35.7M Hold
215,697
9.26% 3
2023
Q1
$33.4M Hold
215,697
8.43% 3
2022
Q4
$38.1M Hold
215,697
7.83% 3
2022
Q3
$35.2M Buy
215,697
+263
+0.1% +$44.5K 8.46% 3
2022
Q2
$38.2M Hold
215,434
10.51% 2
2022
Q1
$38.2M Hold
215,434
11.1% 2
2021
Q4
$36.9M Hold
215,434
10.66% 2
2021
Q3
$34.8M Sell
215,434
-1,753
-0.8% -$299K 11.18% 2
2021
Q2
$35.8M Sell
217,187
-2,941
-1% -$487K 10.56% 2
2021
Q1
$36.2M Hold
220,128
9.17% 2
2020
Q4
$34.6M Buy
220,128
+100,000
+83% +$14.8M 9.47% 2
2020
Q3
$17.9M Buy
120,128
+290
+0.2% +$42.9K 6.29% 3
2020
Q2
$16.9M Buy
119,838
+245
+0.2% +$35.7K 6.37% 3
2020
Q1
$15.7M Buy
119,593
+98,675
+472% +$14M 6.08% 5
2019
Q4
$3.05M Buy
20,918
+1,276
+6% +$173K 2.29% 14
2019
Q3
$2.54M Sell
19,642
-372
-2% -$49K 1.96% 15
2019
Q2
$2.79M Buy
20,014
+73
+0.4% +$10.1K 2.15% 13
2019
Q1
$2.79M Buy
19,941
+245
+1% +$32.8K 2.47% 11
2018
Q4
$2.54M Buy
19,696
+369
+2% +$51.5K 2.54% 10
2018
Q3
$2.67M Buy
19,327
+159
+0.8% +$21.1K 2.35% 10
2018
Q2
$2.33M Buy
19,168
+866
+5% +$108K 2.33% 9
2018
Q1
$2.35M Buy
18,302
+98
+0.5% +$13.2K 2.45% 9
2017
Q4
$2.54M Sell
18,204
-86
-0.5% -$12K 2.47% 7
2017
Q3
$2.38M Sell
18,290
-217
-1% -$28.8K 2.44% 9
2017
Q2
$2.45M Buy
18,507
+151
+0.8% +$19.3K 2.51% 7
2017
Q1
$2.29M Buy
18,356
+558
+3% +$66.7K 2.53% 7
2016
Q4
$2.05M Sell
17,798
-500
-3% -$57.8K 2.44% 7
2016
Q3
$2.16M Sell
18,298
-500
-3% -$60.7K 2.4% 9
2016
Q2
$2.28M Sell
18,798
-178
-0.9% -$20.2K 2.59% 7
2016
Q1
$2.05M Buy
18,976
+118
+0.6% +$12.2K 2.41% 7
2015
Q4
$1.94M Buy
18,858
+97
+0.5% +$9.76K 2.15% 10
2015
Q3
$1.75M Buy
18,761
+380
+2% +$36.8K 2.26% 10
2015
Q2
$1.79M Sell
18,381
-182
-1% -$18.2K 2.12% 10
2015
Q1
$1.87M Sell
18,563
-2,265
-11% -$230K 1.99% 10
2014
Q4
$2.18M Sell
20,828
-50
-0.2% -$5.27K 2.46% 7
2014
Q3
$2.23M Sell
20,878
-1,274
-6% -$132K 2.7% 7
2014
Q2
$2.32M Sell
22,152
-150
-0.7% -$15.2K 2.8% 7
2014
Q1
$2.19M Hold
22,302
2.77% 8
2013
Q4
$2.04M Sell
22,302
-2,856
-11% -$263K 2.75% 10
2013
Q3
$2.18M Buy
25,158
+4,213
+20% +$378K 2.99% 7
2013
Q2
$1.8M Buy
+20,945
New +$1.78M 2.98% 9

Other funds holding JNJ

Drexel Morgan & Co's JNJ Position: Q1 2026 in Review

Drexel Morgan & Co held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 216,207 shares worth $52.8M. The position accounts for 7.75% of the portfolio, ranked #3.

Drexel Morgan & Co first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Drexel Morgan & Co held 216,207 shares of Johnson & Johnson worth $52.8M as of Q1 2026.
  • Drexel Morgan & Co left its Johnson & Johnson share count unchanged in Q1 2026.
  • Johnson & Johnson made up 7.75% of Drexel Morgan & Co's portfolio in Q1 2026, its #3 holding.
  • Drexel Morgan & Co first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Drexel Morgan & Co's 13F filing for Q1 2026, filed 11 May 2026.